Tenet EVP sells 8,000 shares in open market

Tenet Healthcare’s EVP, Chief Administrative Officer and General Counsel, Thomas W. Arnst, reported selling a total of 8,000 shares of common stock in open-market transactions on March 9, 2026.

Rhea-AI Filing Summary

Tenet Healthcare’s EVP, Chief Administrative Officer and General Counsel, Thomas W. Arnst, reported selling a total of 8,000 shares of common stock in open-market transactions on March 9, 2026. He sold 4,714 shares at a weighted average price of $238.42 and 3,286 shares at a weighted average price of $239.46, in multiple trades within disclosed price ranges. Following these sales, he directly holds 12 shares of Tenet Healthcare common stock.

Insider Trade Summary

Net Seller: 8,000 shares

Net Sell 2 txns

Insider Arnst Thomas W

Role EVP, Chief Admin. Officer & GC

Sold 8,000 shs ($1.91M)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,714	$238.42	$1.12M
Sale	Common Stock	3,286	$239.46	$787K

Holdings After Transaction: Common Stock — 12 shares (Direct)

Footnotes (3)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $238.13 to $238.68.
2. F2. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3. F3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $239.25 to $239.59.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Tenet Healthcare (THC) report for Thomas W. Arnst?

Tenet Healthcare reported that Thomas W. Arnst, its EVP, Chief Administrative Officer and General Counsel, sold 8,000 shares of common stock in open-market transactions on March 9, 2026. These sales were disclosed in a Form 4 insider trading report filed with regulators.

How many Tenet Healthcare (THC) shares did Thomas W. Arnst sell and at what prices?

Thomas W. Arnst sold 4,714 Tenet Healthcare common shares at a weighted average price of $238.42 and 3,286 shares at a weighted average price of $239.46. The filing notes these were multiple trades within specified price ranges for each weighted average.

What are the price ranges for Thomas W. Arnst’s Tenet Healthcare (THC) share sales?

For the 4,714-share block, the weighted average price of $238.42 reflects trades between $238.13 and $238.68. For the 3,286-share block, the $239.46 weighted average reflects trades between $239.25 and $239.59, according to the footnotes in the Form 4.

How many Tenet Healthcare (THC) shares does Thomas W. Arnst hold after the reported sales?

After the reported open-market sales on March 9, 2026, Thomas W. Arnst directly holds 12 shares of Tenet Healthcare common stock. The Form 4 lists this post-transaction balance, showing his remaining direct ownership position following the 8,000 total shares sold.

What type of insider transactions did Tenet Healthcare (THC) disclose for Thomas W. Arnst?

The company disclosed two open-market sale transactions in Tenet Healthcare common stock for Thomas W. Arnst, both coded as “S” on the Form 4. These transactions represent non-derivative sales, not option exercises, gifts, or tax-withholding related dispositions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arnst Thomas W

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Admin. Officer & GC

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		S		4,714	D	$238.42(1)(2)	3,298	D
Common Stock	03/09/2026		S		3,286	D	$239.46(2)(3)	12	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $238.13 to $238.68.

2. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $239.25 to $239.59.

	Chad J. Wiener as Attorney-in-Fact for Thomas W. Arnst	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.